209 results
Page 5 of 11
424B5
mzhd7e
8 Nov 19
Prospectus supplement for primary offering
5:03pm
8-K
EX-1.1
chz9as70 vbi
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
424B5
agytb84na50d spx0
6 Nov 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
9cqtggdxhd72rf9hi
28 Oct 19
Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study ofAG-270, a MAT2A Inhibitor, in Patients withMTAP-Deleted Tumors
7:20am
8-K
EX-99.1
97wherj1vbxwi3zvc0iz
1 Aug 19
Agios Reports Business Highlights and Second Quarter 2019 Financial Results
7:29am
8-K
78dtwlw1oqdfzabv
16 Apr 19
Entry into a Material Definitive Agreement
4:06pm